Single-dose pegfilgrastim for the mobilization of allogeneic CD34+ peripheral blood progenitor cells in healthy family and unrelated donors.
Frank Kroschinsky(University Hospital Carl Gustav Carus), Gerhard Ehninger(University Hospital Carl Gustav Carus), Uta Oelschlaegel(University Hospital Carl Gustav Carus), Martin Bornhäuser(Technische Universität Dresden), Gabi Rall, Kristina Hölig(German Red Cross), Rainer Ordemann, Matthias Blechschmidt, Kirsten Poppe‐Thiede, Claudia Rutt, Kristin Zimmer
PubMed
December 1, 2005
Cited by 61
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k
Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial
|The Lancet Oncology|2015|402